A Straight from the Source Webinar Available On-Demand
FDA is encouraging the use of “Digital Evidence” to accelerate product innovation supporting rapid introduction of life-saving technology for patients. “Digital evidence” is already being used at FDA to predict clinical outcomes, inform clinical trial design, support demonstration of safety and effectiveness, identify relevant patient populations, and support regulatory submissions.
Join FDA’s Tina M. Morrison and Axendia’s Daniel R. Matlis for a live webinar on July 10 at 11:00 AM ET.
We will discuss FDA’s perspective on:
- Shifting from traditional evidence sources to digital and real world evidence
- Modeling and Simulation to support improved quality and patient outcomes
- Examples of Digital Evidence currently in use at FDA
- The Review of the Future, harnessing the power digital and real world evidence through digital transformation
Meet Your Trusted Sources
Over 200 FDA employees are part of the Agency’s Modeling and Simulation working group. Find out what they are working on and more.
Register to view this webinar on-demand.
